Issue 7/2018
Content (12 Articles)
EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?
F. Antoñanzas, C. A. Juárez-Castelló, R. Rodríguez-Ibeas
The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study
Wei Yang, Heather Gage, Daniel Jackson, Monique Raats
Health care service utilization of documented and undocumented hired farmworkers in the U.S.
Tianyuan Luo, Cesar L. Escalante
Ebola in the Netherlands, 2014–2015: costs of preparedness and response
Anita W. M. Suijkerbuijk, Corien M. Swaan, Marie-Josee J. Mangen, Johan J. Polder, Aura Timen, Wilhelmina L. M. Ruijs
The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement
Aida Ribera, John Slof, Ignacio Ferreira-González, Vicente Serra, Bruno García-del Blanco, Purificació Cascant, Rut Andrea, Carlos Falces, Enrique Gutiérrez, Raquel del Valle-Fernández, César Morís-de laTassa, Pedro Mota, Juan Francisco Oteo, Pilar Tornos, David García-Dorado
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
Maartje S. Jacobs, Lisa A. de Jong, Maarten J. Postma, Robert G. Tieleman, Marinus van Hulst
The effect of online gambling on gambling problems and resulting economic health costs in Germany
Tobias Effertz, Anja Bischof, Hans-Jürgen Rumpf, Christian Meyer, Ulrich John
Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review
Lidia García-Pérez, Renata Linertová, Margarita Álvarez-de-la-Rosa, Juan Carlos Bayón, Iñaki Imaz-Iglesia, Jorge Ferrer-Rodríguez, Pedro Serrano-Aguilar
Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study
Lisanne I. van Lier, Judith E. Bosmans, Hein P. J. van Hout, Lidwine B. Mokkink, Wilbert B. van den Hout, G. Ardine de Wit, Carmen D. Dirksen, Henk L. G. R. Nies, Cees M. P. M. Hertogh, Henriëtte G. van der Roest
Assessing the opportunity costs of patients with multidrug-resistant organisms in hospitals
Claudia Hübner, Walter Ried, Steffen Flessa
Threshold analysis in the presence of both the diagnostic and the therapeutic risk
Stefan Felder, Thomas Mayrhofer
Impact of specialist rehabilitation services on hospital length of stay and associated costs
A. Duarte, C. Bojke, W. Cayton, A. Salawu, B. Case, L. Bojke, G. Richardson